Stanford University: Head and Neck Neoplasms trials

The registry lists 23 Head and Neck Neoplasms studies with Stanford University as lead sponsor. 3 are open to participants now and 5 have results posted.

Phase 1 3Phase 2 2Phase 3 1No phase 17(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study of a 1-Millimeter Resolution Clinical Positron Emission Tomography (PET) System in Head and Neck Cancer ImagingNot yet recruitingNCT04662554Not applicable
• Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung CancersRecruitingNCT00568490
• Identification and Characterization of Novel Proteins and Genes in Head and Neck CancerRecruitingNCT00230308
• Investigation of Two Swallowing Therapy Models During Radiation Therapy for Head and Neck CancerCompletedNCT03832686Not applicableResults posted
• Engagement of Patients With Advanced CancerCompletedNCT02966509Not applicableResults posted
• Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation TherapyCompletedNCT02369835Phase 3Results posted
• Feasibility of IMRT Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck CancerCompletedNCT01576939Not applicableResults posted
• Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN)CompletedNCT01437449Phase 2Results posted
• Study Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck CancerSuspendedNCT04840472Phase 1
• Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot StudyCompletedNCT03245788Not applicable
• Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck CancerTerminatedNCT01528137Phase 1
• Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR InhibitorsTerminatedNCT01137162
• FNA Tumor Sampling for CD137 Modulation: A Pilot StudyTerminatedNCT01114256
• Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking for Head & Neck CancerTerminatedNCT01011842Not applicable
• Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility StudyCompletedNCT00610415
• Endoscopic Capillary Oximetry for Tumor Diagnosis in Head and Neck CancerTerminatedNCT00568360
• Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic CorrelationCompletedNCT00313027Not applicable
• Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based ContrastCompletedNCT00230295Not applicable
• The Role of FDG PET in Radiation Treatment Planning for Head and Neck CancersCompletedNCT00230269
• Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck CancersCompletedNCT00230256
• A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient PopulationsCompletedNCT00186433
• Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and NeckCompletedNCT00185835Phase 1
• Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00002774Phase 2